Stock SMRN SMARTAG INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Smartag International, Inc.

Equities

SMRN

US8317091002

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Exelixis : and Catalent Enter into Collaboration License and Exclusive Option Agreement to Develop Antibody-Drug Conjugates Leveraging SMARTag Bioconjugation Technology
AQ
Smartag International : SBDG Actively Seeking Acquisitions
AQ
Catalent : Technologies to Enhance Cell Line Productivity and Expand Antibody-Drug Conjugate Therapeutic Window to be presented by Catalent Biologics at PEGS
AQ
Catalent : Triphase Accelerator and Catalent Announce Interim Results of a Dose Escalation Phase 1 Clinical Trial of TRPH-222 in Patients with Non-Hodgkin's Lymphoma
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SMRN Stock
  4. News Smartag International, Inc.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW